NCT02527421View on ClinicalTrials.gov

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

PHASE3TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 19, 2015

Primary Completion Date

March 30, 2019

Study Completion Date

March 30, 2019

Conditions
Plaque Psoriasis
Interventions
DRUG

DFD01 Spray

DFD-01 (betamethasone dipropionate) Spray, 0.05%

Trial Locations (8)

10155

Site 107, New York

76014

Site 106, Arlington

77030

Site 101, Houston

78218

Site 105, San Antonio

91436

Site 102, Encino

92123

Site 100, San Diego

92697-1385

Site 104, Irvine

03756

Site 109, Lebanon

Sponsors
All Listed Sponsors
collaborator

Prosoft Clinical

OTHER

lead

Primus Pharmaceuticals

INDUSTRY